Hemodynamic support with percutaneous devices in patients with heart failure

Heart Failure Clinics

Volumn 11, Issue 2, 2015, Pages 215-230

  Kapur, Navin K ^a   Esposito, Michele ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Assist device; Cardiogenic shock; Decompensated heart failure; ECMO; Impella; Percutaneous mechanical support; Refractory heart failure; TandemHeart

Indexed keywords

ALGORITHM; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CENTRIFUGAL PUMP; COUNTERPULSATION DEVICE; EXTRACORPOREAL OXYGENATION; FEMORAL ARTERY; HEART ASSIST DEVICE; HEART CATHETER; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FAILURE; HIGH RISK PATIENT; HUMAN; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; REVIEW; COMPLICATION; DEVICES; HEALTH SERVICE; HEART VENTRICLE; HEMODYNAMICS; PATHOPHYSIOLOGY; PROCEDURES; SHOCK, CARDIOGENIC;

ASSISTED CIRCULATION; EXTRACORPOREAL MEMBRANE OXYGENATION; HEALTH SERVICES NEEDS AND DEMAND; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; SHOCK, CARDIOGENIC; VENTRICULAR FUNCTION, LEFT;

EID: 84926080739     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2014.12.012     Document Type: Review

References (72)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125(1):e2-e220.
2. Heidenreich P.A., Albert N.M., Allen L.A., et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 2013, 6(3):606-619.
3. Kirklin J.K., Naftel D.C., Pagani F.D., et al. Sixth INTERMACS annual report: a 10,000-patient database. JHeart Lung Transplant 2014, 33:555-564.
4. Stretch R., Sauer C.M., Yuh D.D., et al. National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. JAm Coll Cardiol 2014, 64(14):1407-1415.
5. Cohen M., Urban P., Christenson J.T., et al. Intra-aortic balloon counterpulsation in US and non-US centres: results of the benchmark registry. Eur Heart J 2003, 24(19):1763-1770.
6. Stone G.W., Ohman E.M., Miller M.F., et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. JAm Coll Cardiol 2003, 41(11):1940-1945.
7. Williams D.O., Korr K.S., Gewirtz H., et al. The effect of intraaortic balloon counterpulsation on regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina. Circulation 1982, 66(3):593-597.
8. Kern M.J., Aguirre F., Bach R., et al. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 1993, 87(2):500-511.
9. Kern M.J., Aguirre F.V., Tatineni S., et al. Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. JAm Coll Cardiol 1993, 21(2):359-368.
10. Braunwald E., Sarnoff S.J., Case R.B., et al. Hemodynamic determinants of coronary flow: effect of changes in aortic pressure and cardiac output on the relationship between myocardial oxygen consumption and coronary flow. Am J Physiol 1958, 192(1):157-163.
11. Sarnoff S.J., Braunwald E., Welch G.H., et al. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol 1958, 192(1):148-156.
12. Sarnoff S.J., Case R.B., Welch G.H., et al. Performance characteristics and oxygen debt in a nonfailing, metabolically supported, isolated heart preparation. Am J Physiol 1958, 192(1):141-147.
13. Welch G.H., Braunwald E., Case R.B., et al. The effect of mephentermine sulfate on myocardial oxygen consumption, myocardial efficiency and peripheral vascular resistance. Am J Med 1958, 24(6):871-881.
14. Schreuder J.J., Castiglioni A., Donelli A., et al. Automatic intraaortic balloon pump timing using an intrabeat dicrotic notch prediction algorithm. Ann Thorac Surg 2005, 79(3):1017-1022.
15. Schreuder J.J., Maisano F., Donelli A., et al. Beat-to-beat effects of intraaortic balloon pump timing on left ventricular performance in patients with low ejection fraction. Ann Thorac Surg 2005, 79(3):872-880.
16. Majithia A., Jumean M., Shih H., et al. The hemodynamic effects of the MEGA intra-aortic balloon counterpulsation pump. JHeart Lung Transplant 2013, 32(4S):S226.
17. Kapur NK, Paruchuri V, Majithia A, etal. Hemodynamic effects of standard versus larger capacity intra-aortic balloon counterpulsation pumps. J Inv Card, in press.
18. Charitos C.E., Nanas J.N., Kontoyiannis D.A., et al. The efficacy of the high volume counterpulsation technique at very low levels of aortic pressure. JCardiovasc Surg (Torino) 1998, 39(5):625-632.
19. Weber K.T., Janicki J.S., Walker A.A. Intra-aortic balloon pumping: an analysis of several variables affecting balloon performance. Trans Am Soc Artif Intern Organs 1972, 18(0):486-492.
20. Papaioannou T.G., Mathioulakis D.S., Nanas J.N., et al. Arterial compliance is a main variable determining the effectiveness of intra-aortic balloon counterpulsation: quantitative data from an invitro study. Med Eng Phys 2002, 24(4):279-284.
21. Stamatelopoulos S.F., Nanas J.N., Saridakis N.S., et al. Treating severe cardiogenic shock by large counterpulsation volumes. Ann Thorac Surg 1996, 62(4):1110-1117.
22. Ferguson J.J., Cohen M., Freedman R.J., et al. The current practice of intra-aortic balloon counterpulsation: results from the benchmark registry. JAm Coll Cardiol 2001, 38(5):1456-1462.
23. Eltchaninoff H., Dimas A.P., Whitlow P.L. Complications associated with percutaneous placement and use of intraaortic balloon counterpulsation. Am J Cardiol 1993, 71(4):328-332.
24. Erdogan H.B., Goksedef D., Erentug V., et al. In which patients should sheathless IABP be used? An analysis of vascular complications in 1211 cases. JCard Surg 2006, 21(4):342-346.
25. Abdel-Wahab M., Saad M., Kynast J., et al. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2010, 105(7):967-971.
26. Curtis J.P., Rathore S.S., Wang Y., et al. Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the national cardiovascular data registry. Circ Cardiovasc Qual Outcomes 2012, 5(1):21-30.
27. Patel M.R., Smalling R.W., Thiele H., et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA 2011, 306(12):1329-1337.
28. Thiele H., Schuler G., Neumann F.J., et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J 2012, 163(6):938-945.
29. O'Neill W.W., Kleiman N.S., Moses J., et al. Aprospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 2012, 126(14):1717-1727.
30. Perera D., Stables R., Clayton T., et al. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation 2013, 127(2):207-212.
31. Perera D., Stables R., Thomas M., et al. Electiveintra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA 2010, 304(8):867-874.
32. Valgimigli M., Steendijk P., Serruys P.W., et al. Use of Impella Recover(R) LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findings. EuroIntervention 2006, 2:91-100.
33. Remmelink M., Sjauw K.D., Henriques J.P., et al. Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv 2010, 75:187-194.
34. Sauren L.D., Accord R.E., Hamzeh K., et al. Combined Impella and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: an experimental study. Artif Organs 2007, 31:839-842.
35. Kapur N.K., Paruchuri V., Pham D.T., et al. Hemodynamic effects of left atrial or left ventricular cannulation for acute circulatory support in a bovine model of left heart injury. ASAIO J 2014, [Epub ahead of print].
36. Sjauw K.D., Konorza T., Erbel R., et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. JAm Coll Cardiol 2009, 54(25):2430-2434.
37. Maini B., Naidu S.S., Mulukutla S., et al. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: The USpella Registry. Catheter Cardiovasc Interv 2012, 80(5):717-725.
38. Seyfarth M., Sibbing D., Bauer I., et al. Arandomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intraaortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. JAm Coll Cardiol 2008, 52:1584-1588.
39. Griffith B.P., Anderson M.B., Samuels L.E., et al. The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. JThorac Cardiovasc Surg 2013, 145:548-554.
40. Lemaire A., Anderson M.B., Lee L.Y., et al. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock. Ann Thorac Surg 2014, 97(1):133-138.
41. Kar B., Gregoric I.D., Basra S.S., et al. The percutaneous ventricular assist device in severe refractory cardiogenic shock. JAm Coll Cardiol 2011, 57:688-696.
42. Burkhoff D., Naidu S.S. The science behind percutaneous hemodynamic support: a review and comparison of support strategies. Catheter Cardiovasc Interv 2012, 80:816-829.
43. Kono S., Nishimura K., Nishina T., et al. Autosynchronized systolic unloading during left ventricular assist with a centrifugal pump. JThorac Cardiovasc Surg 2003, 125:353-360.
44. Goldstein A.H., Pacella J.J., Clark R.E. Predictable reduction in left ventricular stroke work and oxygen utilization with an implantable centrifugal pump. Ann Thorac Surg 1994, 58:1018-1024.
45. Burkhoff D., Cohen H., Brunckhorst C., et al. Arandomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006, 152:e1-e8.
46. Thiele H., Sick P., Boudriot E., et al. Randomized comparison of intra-aortic balloon support versus a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005, 26:1276-1283.
47. Cheng J.M., den Uil C.A., Hoeks S.E., et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 2009, 30(17):2102-2108.
48. Boulate D., Luyt C.E., Pozzi M., et al. Acute lung injury after mechanical circulatory support implantation in patients on extracorporeal life support: an unrecognized problem. Eur J Cardiothorac Surg 2013, 44(3):544-550.
49. Leick J., Liebetrau C., Szardien S., et al. Door-to-implantation time of extracorporeal life support systems predicts mortality in patients with out-of-hospital cardiac arrest. Clin Res Cardiol 2013, 102:661-669.
50. Allen S., Holena D., McCunn M., et al. Areview of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ECMO) in critically ill adult patients. JIntensive Care Med 2011, 26(1):13-26.
51. Ghio S., Gavazzi A., Campana C., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. JAm Coll Cardiol 2001, 37:183-188.
52. Zehender M., Kasper W., Kauder E., et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. NEngl J Med 1993, 328:981-988.
53. Jacobs A.K., Leopold J.A., Bates E., et al. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. JAm Coll Cardiol 2003, 41:1273-1279.
54. Budweiser S., Jörres R.A., Riedl T., et al. Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest 2007, 131(6):1650-1658.
55. Benza R.L., Miller D.P., Gomberg-Maitland M., et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010, 122:164-172.
56. Haddad F., Peterson T., Fuh E., et al. Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension. Circ Heart Fail 2011, 4:692-699.
57. Apostolakis S., Konstantinides S. The right ventricle in health and disease: insights into physiology, pathophysiology and diagnostic management. Cardiology 2012, 121(4):263-273.
58. Sanchez O., Planquette B., Roux A., et al. Triaging in pulmonary embolism. Semin Respir Crit Care Med 2012, 33:156-162.
59. Greyson C.R. Pathophysiology of right ventricular failure. Crit Care Med 2008, 36:S57-S65.
60. Atiemo A.D., Conte J.V., Heldman A.W. Resuscitation and recovery from acute right ventricular failure using a percutaneous right ventricular assist device. Catheter Cardiovasc Interv 2006, 68(1):78-82.
61. Takagaki M., Wurzer C., Wade R., et al. Successful conversion of TandemHeart left ventricular assist device to right ventricular assist device after implantation of a HeartMate XVE. Ann Thorac Surg 2008, 86:1677-1679.
62. Rajdev S., Benza R., Misra V. Use of tandem heart as a temporary hemodynamic support option for severe pulmonary artery hypertension complicated by cardiogenic shock. JInvasive Cardiol 2007, 19(8):E226-E229.
63. Bajona P., Salizzoni S., Brann S.H., et al. Prolonged use of right ventricular assist device for refractory graft failure following orthotopic heart transplantation. JThorac Cardiovasc Surg 2010, 139(3):e53-e54.
64. Kapur N.K., Paruchuri V., Korabathina R., et al. Effects of a percutaneous mechanical circulatory support device for medically refractory right ventricular failure. JHeart Lung Transplant 2011, 30(12):1360-1367.
65. Kapur N.K., Paruchuri V., Jagannathan A., et al. Mechanical circulatory support for right ventricular failure: the TandemHeart in RIght VEntricular support (THRIVE) Registry. JACC Heart Fail 2013, 1(2):127-134.
66. Cheung A.W., White C.W., Davis M.K., et al. Short-term mechanical circulatory support for recovery from acute right ventricular failure: clinical outcomes. JHeart Lung Transplant 2014, 33(8):794-799.
67. The use of Impella RP support system in patients with right heart failure. Available at: Accessed October 27, 2014. http://clinicaltrials.gov/show/NCT01777607.
68. Rajagopalan N., Yanagida R., Hoopes C.W. Insertion of Impella 5.0 to improve candidacy for HeartMate II left ventricular assist device placement. JInvasive Cardiol 2014, 26(4):E40-E41.
69. Estep J.D., Cordero-Reyes A.M., Bhimaraj A., et al. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. JACC Heart Fail 2013, 1(5):382-388.
70. Smalling R.W., Cassidy D.B., Barrett R., et al. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. A comparison with intra-aortic balloon counterpulsation and reperfusion alone in a canine infarction model. Circulation 1992, 85:1152-1159.
71. Meyns B., Stolinski J., Leunens V., et al. Left ventricular support by catheter-mounted axial flow pump reduces infarct size. JAm Coll Cardiol 2003, 41:1087-1095.
72. Kapur N.K., Paruchuri V., Urbano-Morales J.A., et al. Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size. Circulation 2013, 128(4):328-336.